Literature DB >> 14233145

CONTRASTING INCIDENCE OF ACUTE MONOCYTIC AND GRANULOCYTIC LEUKEMIAS IN P32-TREATED PATIENTS WITH POLYCYTHEMIA VERA AND CHRONIC LYMPHOCYTIC LEUKEMIA.

E E OSGOOD.   

Abstract

Entities:  

Keywords:  LEUKEMIA, LYMPHOCYTIC; LEUKEMIA, MONOCYTIC; LEUKEMIA, RADIATION-INDUCED; NEOPLASM STATISTICS; PHOSPHORUS ISOTOPES; POLYCYTHEMIA VERA

Mesh:

Substances:

Year:  1964        PMID: 14233145

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


× No keyword cloud information.
  9 in total

1.  [Nosological significance of preleukemia].

Authors:  H Brücher
Journal:  Blut       Date:  1973-04

2.  [Lymphosarcomatosis in the course of a chronic lymphatic leukemia].

Authors:  D Müller; W Langer; W Wilmanns; H V Gärtner; G Schubert
Journal:  Blut       Date:  1972-01

3.  [Late results of radiophosphorus therapy in polycythemia vera].

Authors:  R Höfer; J Kühböck
Journal:  Blut       Date:  1970-04

4.  Treatment of polycythaemia vera.

Authors:  P J Watkins; G H Fairley; R B Scott
Journal:  Br Med J       Date:  1967-06-10

Review 5.  The iatrogenic leukaemias induced by radio- and/or chemotherapy.

Authors:  Y Najean
Journal:  Med Oncol Tumor Pharmacother       Date:  1987

Review 6.  Historical review of the causes of cancer.

Authors:  Clarke Brian Blackadar
Journal:  World J Clin Oncol       Date:  2016-02-10

Review 7.  Transformation of a chronic myeloproliferative neoplasm to acute myelogenous leukemia: does anything work?

Authors:  Madappa N Kundranda; Raoul Tibes; Ruben A Mesa
Journal:  Curr Hematol Malig Rep       Date:  2012-03       Impact factor: 3.952

8.  Blast cells with monoclonal surface immunoglobulin in two cases of acute blast crisis supervening on chronic lymphocytic leukaemia.

Authors:  J C Brouet; J L Preud'Homme; M Seligmann; J Bernard
Journal:  Br Med J       Date:  1973-10-06

9.  Use and risks of phosphorus-32 in the treatment of polycythaemia vera.

Authors:  Claude Parmentier
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-09-03       Impact factor: 9.236

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.